Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025)
Benitec Biopharma (BNTC) posted Change in Accured Expenses of $19000.0 for Q4 2025, down 48.65% sequentially from $37000.0 in Q3 2025, and up 120.43% YoY from $8619.5 in Q4 2024.
Powered by 
Analysis
Benitec Biopharma (BNTC) Change in Accured Expenses (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Change in Accured Expenses for 7 years, with the latest figure at $19000.0 in Q4 2025.
- Quarterly Change in Accured Expenses rose 120.43% year-over-year to $19000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52000.0 (up 161.9% YoY) and the FY2025 annual result came in at -$81000.0, down 307.69% from the prior year.
- Change in Accured Expenses declined to $19000.0 in Q4 2025 per BNTC's latest filing, from $37000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $159000.0 in Q1 2025 and troughed at -$163000.0 in Q2 2025.
- A 5-year average of $13150.0 and a median of $17500.0 in 2024 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 7850.0% in 2025, down 1711.11% in 2025.
- Over 5 years, Change in Accured Expenses stood at $3000.0 in 2021, then surged by 100.0% to $6000.0 in 2022, then jumped by 733.33% to $50000.0 in 2023, then slumped by 286.0% to -$93000.0 in 2024, then soared by 120.43% to $19000.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $19000.0, $37000.0, and -$163000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | -159,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | -8,000.00 |
| Jun 30, 2021 | 66,000.00 |
| Mar 31, 2021 | 30,000.00 |